Radiologists Look for Ways to Conserve amidst the Dye Shortage
Antitrust Lawsuit against Generic Pharmaceutical Companies Is Amended
Women Are Underrepresented in Clinical Trials, Leading to Health Inequity
USPTF Updates Recommendations on Supplements to Prevent Cancer
Epilepsy Drug Prices Have Increased by 277% in the Past Decade
How Data, Apps, and Hackers Are Reshaping Healthcare
FDA Expanded Approval of Skyrizi for Treatment of Crohn’s Disease
Vagus Nerve Stimulation Augments Behaviors in Epilepsy Patients
Pfizer Acquires ReViral for $525M, Renews Pharma Acquisition Spree
FDA Approved Weight-Management Treatment for Bardet–Biedl Syndrome
Beta Bionics Shares Clinical Trial Data on Bionic Pancreas for Type 1 Diabetes
Could the Approval of Albrioza by Health Canada for ALS Impact the FDA Ruling?
FDA Advisory Board Unanimously Votes to Approve Pfizer COVID Vaccine for Kids under 5
FDA Accepts Biologic Application for Keytruda Treatment of Lung Cancer
Olumiant Becomes the First FDA-Approved Systemic Treatment for Alopecia Areata
Eli Lilly Sued by Whistleblower for Pharmaceutical Manufacturing Issue
Bluebird Bio’s Rare Disease Gene Therapies Recommended for FDA Approval
US FDA Approves GSK’s Priorix Measles, Mumps, and Rubella Vaccine
CDC Report Links People Seeking Substance Misuse Treatment to Psychiatric Issues
FDA Recommends Emergency Use for Novavax Coronavirus Vaccine
Researchers Discover Promising Compound That Kills Hard-to-Treat Cancer Cells
FDA Refuses to File Aeglea Biologics License Application
Pfizer-BioNTech’s Expanding Coronavirus Vaccine FDA Approval
Nephron Pharmaceuticals Recalls 2.1 Million Doses of Medicine, Medical Equipment
Study Finds Vaccination During Pregnancy Decreases Baby’s COVID-19 Risk
Novartis Gains FDA Approval for Follicular Lymphoma Cell Therapy
Academia Partners with Pharma to Discover New SARS-CoV-2 Drug Treatments